Vessel-sparing prostate radiotherapy: Dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI

« Previous Next »International Journal of Radiation Oncology * Biology * Physics
Volume 61, Issue 1 , Pages 20-31, January 2005

Patrick W. McLaughlin, M.D.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
- Department of Radiation Oncology, Providence Cancer Center, Southfield, MI, USA
- Reprint requests to: Patrick W. McLaughlin, M.D., University of Michigan Medical Center, Department of Radiation Oncology, 1500 E. Medical Center Dr., Ann Arbor, MI 48109. Tel: (248) 849-3321; Fax: (248) 849-8448
Vrinda Narayana, Ph.D.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
- Department of Radiation Oncology, Providence Cancer Center, Southfield, MI, USA
Amichay Meirowitz, M.D.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
Sara Troyer, B.S.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
Peter L. Roberson, Ph.D.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
Roger Gonda Jr., M.D.
- Department of Radiology, Providence Hospital, Southfield, MI, USA
Howard Sandler, M.D.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
Lon Marsh
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
Theodore Lawrence, M.D.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA
Marc Kessler, Ph.D.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA